Breakthrough in Cancer Gene Therapy: Hyaluronic Acid-Modified Epigallocatechin Gallate Nanoliposomes Show Promise

Strategic Insights -

Researchers from Shenyang Pharmaceutical University have made a significant discovery in the field of cancer gene therapy, developing a novel hyaluronic acid (HA)-modified epigallocatechin gallate (EGCG)-loaded liposome that enhances stability and anticancer efficacy against A549 cells. The study, published in Carbohydrate Polymer Technologies and Applications, found that the HA-PL-EGCG-LIP nanoliposomes achieved encapsulation efficiency of 94.71% and showed stronger antitumor efficacy compared to non-HA-modified liposomes.

Key Takeaways:

  • The HA-PL-EGCG-LIP nanoliposomes exhibited improved stability and anticancer activity against A549 cells, with only 49.73% cell viability at a concentration of 200 mM.
  • The in vitro release profile of the liposomes was assessed through Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction, thermogravimetric analysis, and differential scanning calorimetry (TG-DSC).
  • The impact of the liposomes on human lung adenocarcinoma A549 cells was evaluated through assessments of antitumor efficacy, flow cytometry, and fluorescence microscopy.
  • The HA-PL-EGCG-LIP nanoliposomes showed enhanced cellular internalization via HA/CD44-mediated pathways.
  • This nanofomulation has potential medical applications as a functional food additive for daily supplementation and as a preventive agent for at-risk populations.
  • The authors suggest that the HA-PL-EGCG-LIP nanoliposomes may serve as a promising therapeutic agent for cancer treatment.

Statistics:

  • Encapsulation efficiency (EE) of HA-PL-EGCG-LIP nanoliposomes: 94.71% (p < 0.05)
  • Particle size of HA-PL-EGCG-LIP nanoliposomes: 159.0 nm
  • Antitumor efficacy of HA-PL-EGCG-LIP nanoliposomes against A549 cells: 49.73% at 200 mM concentration

Sources:

  • Lv, J., Ma, Z., Zhang, S., Gao, S., Wang, F., Li, D., Zhang, X., & Sun, B. (2025). Hyaluronic acid-modified epigallocatechin gallate nanoliposomes:Preparation and evaluation of the stability and anticancer activity. Carbohydrate Polymer Technologies and Applications, 11(), 100892.
  • (2025, September 9). Researchers' Work from Shenyang Pharmaceutical University Focuses on Cancer Gene Therapy (Hyaluronic acid-modified epigallocatechin gallate nanoliposomes:Preparation and evaluation of the stability and anticancer activity). Cancer Weekly, p 72.